Healthcare
Q & M Dental to acquire SG dental group with $34m profit guarantee
Q & M Dental to acquire SG dental group with $34m profit guarantee
The acquisition will be funded through a mix of cash and new ordinary shares.
OUE Limited narrows loss to $279.1m in 2025
It was mainly due to the absence of fair value loss and lower finance expenses.
IHH Healthcare FY2025 net profit falls 21% to $682.67m
The decrease is due to unrealised currency translation losses from a stronger ringgit.
iX Biopharma secures $52.8m US contract for pain reliever trials
The funding will be allocated for the late-stage development of Wafermine.
Hyphens Pharma profit dives 44% in 2025 despite record 40.7% gross margins
Net profit fell to $6.1m in 2025 as higher costs and inventory write-offs offset proprietary brand growth.
Raffles Medical PATMI up 13.4% on stronger hospital services, insurance arm
Hospital services accounted for $41.1m of the profit.
iX Biopharma gets SGX nod to list 75.8 million shares in $6m placement
The company entered a placement agreement with OCBC.
Singapore Paincare sinks to net loss on rising staff expenses
The group posted a $47,000 net loss in HY2026, reversing last year’s $781,000 profit.
iX Biopharma narrows losses in H1 FY 2026 despite 14% fall in revenue
Net loss narrowing to $2.1m, compared with a loss of $6.3m in 1H FY 2025.
Singapore Paincare expands operations and client base with TS Medical acquisition
The SGX-listed group acquired 51% of the company which operates Doctors for Life Medical.
Precision for Medicine widens APAC reach with new Singapore office
The new office will serve as its APAC hub for biomarker research.
SMART and NUS weaponize AI to give soft robots human-like reflexes
The system reduced tracking error by 44% to 55% under heavy disturbances.
AJJ, Huaxi unveil eldercare robot roadmap after HSA milestone
Robot clears HSA Class A device notification.
NTU, Gu Sheng Tang push TCM research with $1.06m programme
Visiting experts from China will provide clinical mentorship for local practitioners.
$45b state surge triggers global VC influx to Singapore’s Biopolis
The 2% GDP spend on R&D served as a talent magnet for returning overseas scientists.
HSA clears cancer-detecting AI for routine hospital use
Intelligent Scopes Corp secures regulatory green light for its new bladder cancer software.
Health Information Bill compels providers to share patient data
The new bill is expected to take effect in early 2027.
Read Here
Advertise
Sign Up
![[Singapore Business Review] Report on the Asian Business Channel](https://www.cmgassets.com/s3fs-public/styles/video_thumbnail/public/2026-10/full-show-thumbnail_1.png.webp?VersionId=bJbrT_JKOuMWBnf7YkmsWjOSWIXddSvY&itok=zWuxHRNG)
Commentary
Singapore’s small exporters need credit that matches their payment cycle
The hidden realities of succession for next-gen heirs
In Asia, fintech leaders must compete on credibility
F1 on a gravel road: Why AI is still stuck in first gear
Why AI blocklists give Singapore firms a false sense of security
When scale arrives before proof: Singapore’s capital allocation question in Southeast Asia
Rethinking fleet ownership in a changing business landscape
Beyond the chips: The materials behind Singapore’s AI infrastructure
How homegrown brands are redefining premium in Asia
AI in hospitality: Where should Singapore’s F&B operators draw the line?